病毒学和临床反应的动力学参数的布莱维尔提德治疗D型肝炎:现实世界的数据
Alexander Killer1, Smaranda Gliga1, Carolin Lohr1
1Department for Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Gastro hep advances
|August 12, 2024
概括
针对乙型肝炎病毒 (HDV) 感染的布莱维尔提德治疗显示出肝脏的快速改善,ALT正常化之前的病毒反应. 延迟反应的预测因素包括严重的肝炎,低的BMI和高的α-fetoprotein.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝炎D病毒 (HDV) 感染缺乏特定的治疗方法.
- 布列维尔提德是HDV的第一个进入抑制剂.
- 了解布莱维尔提德反应动态和预测因素至关重要.
研究的目的:
- 分析HDV患者对布莱维尔提德的反应动态.
- 确定治疗结果的临床预测因素.
- 为了评估布莱维尔提德的安全性和有效性.
主要方法:
- 对15名HDV患者的回顾性分析,这些患者接受了布莱维尔提德治疗.
- 每月进行实验室监测和每季度进行过渡性弹性图像.
- 12个月的治疗时间.
主要成果:
- 治疗反应率与临床试验相似.
- 氨酸氨基转移酶 (ALT) 的正常化通常在2-6个月内发生.
- 在≥6个月后观察到病毒学反应;延迟反应与基线严重程度,低BMI和高α-fetoprotein相关.
- 三分之一的患者在≥1年后实现了HDV-RNA损失.
结论:
- 布列维尔提德是一种安全有效的HDV治疗方法,可诱导快速的肝病学反应.
- 肝病学反应 (ALT降低) 在病毒学反应之前.
- 在高病毒载量和ALT患者中观察到较慢的响应;非响应者仍然显示病毒血量减少.
- 需要进一步的研究来确定最佳的布莱维尔单一治疗持续时间.
相关概念视频
Retrovirus Life Cycles
45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K
Volume of Distribution
152
The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
152


